Effect of misoprostol and cimetidine on gastric cell labeling index
- PMID: 3924719
- DOI: 10.1016/0016-5085(85)90745-0
Effect of misoprostol and cimetidine on gastric cell labeling index
Abstract
The effect of misoprostol and cimetidine on gastric cell turnover was studied. Endoscopic biopsy specimens of fundic and antral mucosa were obtained from duodenal ulcer patients before and after 4 wk of therapy with cimetidine 1.2 g/day or misoprostol 800 micrograms/day. Biopsy specimens were incubated with [3H]thymidine. Glandular column length and number of labeled cells were determined after autoradiography. There was no significant difference in column length of antral or fundic glands before or after therapy with cimetidine and misoprostol. The number of antral and fundic labeled cells was significantly decreased after misoprostol treatment (3.6 +/- 0.3 and 4.6 +/- 0.4, mean +/- SE), as opposed to their respective number before therapy (6.9 +/- 0.5 and 8.3 +/- 0.8) (p less than 0.01). On the other hand, after treatment with cimetidine, the number of antral and fundic labeled cells was significantly higher (11.8 +/- 0.9 and 7.5 +/- 1.0, respectively) as compared with their number before therapy (5.7 +/- 0.5 and 5.6 +/- 0.6, respectively). The decreased gastric cell turnover induced by misoprostol indicates that the trophic effect of prostanoids on gastric mucosa is not due to an increase in cellular kinetics. The increased gastric cell turnover induced by cimetidine may contribute to its therapeutic effect in peptic ulcer disease.
Similar articles
-
Effect of misoprostol and cimetidine on gastric cell turnover.Dig Dis Sci. 1985 Nov;30(11 Suppl):133S-135S. doi: 10.1007/BF01309399. Dig Dis Sci. 1985. PMID: 3932045
-
Efficacy of prostanoids in the treatment of gastric ulcer.Clin Invest Med. 1987 May;10(3):238-42. Clin Invest Med. 1987. PMID: 3113800 Clinical Trial.
-
Effect of cimetidine on gastric mucosal cell proliferation in man.Scand J Gastroenterol. 1986 Dec;21(10):1271-4. doi: 10.3109/00365528608996454. Scand J Gastroenterol. 1986. PMID: 3810001
-
The therapeutic efficacy of misoprostol in peptic ulcer disease.Postgrad Med J. 1988;64 Suppl 1:60-77. Postgrad Med J. 1988. PMID: 3138682 Review.
-
Overview of misoprostol clinical experience.Dig Dis Sci. 1986 Feb;31(2 Suppl):47S-54S. doi: 10.1007/BF01309323. Dig Dis Sci. 1986. PMID: 3080288 Review.
Cited by
-
Prostaglandins and the gastric epithelium: effects of misoprostol on gastric epithelial cell proliferation in the dog.Gut. 1989 Mar;30(3):316-21. doi: 10.1136/gut.30.3.316. Gut. 1989. PMID: 2496010 Free PMC article.
-
Time-related interference of misoprostol with experimental gastric cancer formation induced by N-methyl-N'-nitro-N-nitrosoguanidine in the rat.J Cancer Res Clin Oncol. 1992;118(6):441-6. doi: 10.1007/BF01629427. J Cancer Res Clin Oncol. 1992. PMID: 1618891 Free PMC article.
-
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.Drugs. 1987 Jan;33(1):1-30. doi: 10.2165/00003495-198733010-00001. Drugs. 1987. PMID: 3102205 Review.
-
Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine.Dig Dis Sci. 1987 Aug;32(8):851-6. doi: 10.1007/BF01296708. Dig Dis Sci. 1987. PMID: 3301232 Clinical Trial.
-
Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.Drugs. 1989 Apr;37(4):391-401. doi: 10.2165/00003495-198937040-00001. Drugs. 1989. PMID: 2567661 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources